









Markets
/
Stocks
/
nasdaq-sgp
/

SpyGlass Pharma Ord shs (Proposed)

SGP

22.610USD

-2.590-10.28%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

721.51MMarket Cap

LossP/E TTM



SpyGlass Pharma Ord shs (Proposed)

22.610

-2.590-10.28%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

You can check out the annual or quarterly balance sheets of SpyGlass Pharma Ord shs (Proposed) here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Total equity

Cash, cash equivalents and short-term investments

--118.04M

- Cash and cash equivalents

--106.01M

-Short-term investments

--12.03M

Receivables

--418.01K

-Other receivables

--418.01K

Prepaid expenses

--1.23M

Other current assets

--10.42K

Total current assets

--119.70M

Non-current assets

Net Fixed Assets

--5.13M

-Fixed Assets

--6.06M

-Accumulated depreciation

--933.75K

Other non-current assets

--2.19M

Total non-current assets

--7.32M

Total assets

--127.01M

Liabilities

Current liabilities

-Other payables

--3.16M

Accrued expenses

--1.29M

Other current liabilities

--3.16M

Total current liabilities

--6.61M

Non-current liabilities

Long-term debt and lease liabilities

--3.09M

-Long-term lease liabilities

--3.09M

Total non-current liabilities

--3.09M

Total liabilities

--9.70M

Shareholders' equity

Common equity

--4.95M

Preferred equity

--77.06M

Retained earnings

---92.18M

Capital reserves

--4.95M

Total equity

--117.31M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

